Exelixis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Exelixis 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About EXEL
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic.
CEOMichael M. Morrissey
CEOMichael M. Morrissey
Employees1,147
Employees1,147
HeadquartersAlameda, California
HeadquartersAlameda, California
Founded1994
Founded1994
Employees1,147
Employees1,147
EXEL Key Statistics
Market cap11.26B
Market cap11.26B
Price-Earnings ratio17.51
Price-Earnings ratio17.51
Dividend yield—
Dividend yield—
Average volume2.74M
Average volume2.74M
High today$42.04
High today$42.04
Low today$41.33
Low today$41.33
Open price$41.66
Open price$41.66
Volume2.12M
Volume2.12M
52 Week high$49.62
52 Week high$49.62
52 Week low$31.90
52 Week low$31.90
Stock Snapshot
With a market cap of 11.26B, Exelixis(EXEL) trades at $41.98. The stock has a price-to-earnings ratio of 17.51.
As of 2025-12-17, Exelixis(EXEL) stock has fluctuated between $41.33 and $42.04. The current price stands at $41.98, placing the stock +1.6% above today's low and -0.1% off the high.
Exelixis(EXEL) shares are trading with a volume of 2.12M, against a daily average of 2.74M.
During the past year, Exelixis(EXEL) stock moved between $31.90 at its lowest and $49.62 at its peak.
During the past year, Exelixis(EXEL) stock moved between $31.90 at its lowest and $49.62 at its peak.
Analyst ratings
50%
of 22 ratingsBuy
50%
Hold
50%
Sell
0%
People also own
Based on the portfolios of people who own EXEL. This list is generated using Robinhood data, and it’s not a recommendation.